Keyword: Pershing Square Capital Management
News
23.03.2016
- J. Michael Pearson has stepped down as CEO of Canada-based Valeant Pharmaceuticals two months after returning from a medical leave, as the company’s stock continues to bleed. One...
News
24.04.2015
- US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...
News
19.02.2015
- Three months after acquiring US Botox producer Allergan for $66 billion, Ireland-based drugmaker Actavis has announced it will adopt Allergan as the name of the merged corporate...
News
17.09.2014
- US drugmaker Allergan, which makes the Botox anti-wrinkle treatment, said it has reached agreement with suitors Pershing Square Capital Management and Canada's Valeant...
News
19.06.2014
- Canada's Valeant Pharmaceuticals is taking its hostile $50.8 billion bid to acquire Botox manufacturer Allergan directly to shareholders. Backed by activist shareholder Bill Ackman...
News
14.05.2014
- A day after U.S. drugmaker Allergan rejected its initial takeover approach, Canada's Valeant Pharmaceuticals International said it would "improve" the unsolicited $47 billion offer...
